Tag: clinical trials
-
A.I. Mammogram Screening Shown to Improve Cancer Detection
Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists.
-
Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections.
-
Trial Begins for Multi-Neurological Disease Therapy
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.
-
Grant Funds Typhoid Vaccine Patch Development
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device.
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
-
Biotech, A.I. Companies Model Animal Studies/Clinical Trials
A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
-
Trial Underway Testing Stem Cell Particles for Burns
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells.
-
Advanced Encryption Shown to Enable Cancer Data Sharing
Data scientists and cancer specialists demonstrate a data encryption technique that makes possible real-world cancer data sharing while preserving individual privacy.
-
Health App Shown to Improve Asthma, Depression Outcomes
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.